This journal explores the evolution of HIV diagnostic testing, from early antibody-based methods to advanced molecular and rapid point-of-care technologies. It highlights the impact of these innovations on early detection, treatment initiation, and global efforts to control HIV transmission.
This webinar is about improving maternal health lessons learned from states addressing congenital syphilis.
This journal discusses the role of core group theory in understanding the transmission dynamics of mpox, emphasizing that the virus primarily spreads through sexual contact and behaves similarly to other sexually transmitted infections. It highlights how infection-induced and vaccine-induced immunity within high-risk groups have significantly reduced transmission, making future large-scale outbreaks unlikely, though continued surveillance and vaccination efforts remain essential.
This 30-minute podcast was created in recognition of World TB Day. In the recording, Dr. Zelalem Temesgen discusses TB, including information on TB diagnosis and management.
NASTAD highlights the achievements of the 47 Ending the HIV Epidemic (EHE) Phase 1 jurisdictions through a series of success stories featured on a dedicated webpage. These stories demonstrate innovative strategies addressing the four pillars of EHE: Diagnose, Treat, Prevent, and Respond. Supported by the Health Resources and Services Administration (HRSA), this initiative aims to strengthen programs for individuals living with and at risk for HIV.
This information guide is intended for health care professionals involved in care of persons interested in or receiving doxycycline postexposure prophylaxis (doxy PEP) for STI prevention. The information in this guide pertains to the use of doxy PEP for STI postexposure prophylaxis.
This webinar discusses that with reported cases of syphilis up 80% since 2018 and more than 3,700 babies born with syphilis in 2022, it’s important to learn more about this curable STI and how to protect yourself from serious health consequences.
NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 2: Part 2: Current Methadone Access: Where are we now?” webinar on September 24 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.
NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.
NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.
